Literature DB >> 19150558

A comparative study of quality of life issues relating to open versus laparoscopic nephrectomy: a prospective pragmatic study.

Ondina A Harryman1, Kim Davenport, Stephen Keoghane, Francis X Keeley, Anthony G Timoney.   

Abstract

PURPOSE: We determined whether laparoscopic nephrectomy confers improved health related quality of life in the early postoperative period compared with open nephrectomy.
MATERIALS AND METHODS: Patients undergoing open or laparoscopic nephrectomy were prospectively recruited. Patients completed the Comorbidity Symptom Scale preoperatively as well as the SF-36(R) quality of life health survey and pain visual analog scale preoperatively, and 2 days and 1 month postoperatively.
RESULTS: A total of 100 patients were recruited, of whom 71 completed all questionnaires, including 38 in the laparoscopic group and 33 in the open group. In the 2 groups mean patient age was the same (56.8 years) and there was a similar sex distribution. The laparoscopic group had improved quality of life scores with significantly higher physical component scores 1 month postoperatively vs the open group (-5.7% vs -22.2%, p = 0.009). The laparoscopic group also had significantly higher mental component scores 2 days postoperatively vs the open group compared to baseline (6.0% vs -6.6%, p = 0.009). The laparoscopic group had significantly lower pain visual analog scale scores 1 month postoperatively compared to baseline. Patients with higher Comorbidity Symptom Scale scores were more likely to undergo a laparoscopic approach (p = 0.036). Despite this they had a significantly shorter hospital stay (4 vs 6 days, p <0.001).
CONCLUSIONS: Quality of life benefits of laparoscopic over open nephrectomy were found in the early postoperative period despite more comorbidities in the laparoscopic group. This provides further evidence of the benefits of the laparoscopic approach over open surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19150558     DOI: 10.1016/j.juro.2008.11.028

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Comprehensive assessment of quality of life and psychosocial adjustment in patients with renal tumors undergoing open, laparoscopic and nephron sparing surgery.

Authors:  Patricia A Parker; Richard Swartz; Bryan Fellman; Diana Urbauer; Yisheng Li; Louis L Pisters; Charles J Rosser; Christopher G Wood; Surena F Matin
Journal:  J Urol       Date:  2012-01-15       Impact factor: 7.450

Review 2.  Robot-assisted partial nephrectomy: current status, techniques, and future directions.

Authors:  Paurush Babbar; Ashok K Hemal
Journal:  Int Urol Nephrol       Date:  2011-02-25       Impact factor: 2.370

Review 3.  Pushing the Envelope: Laparoscopic Nephrectomy as Outpatient Surgery.

Authors:  Nessn H Azawi; Tom Christensen; Claus Dahl; Lars Lund
Journal:  Curr Urol Rep       Date:  2018-01-27       Impact factor: 3.092

4.  Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: Adjusting for the burden of ensuing chronic kidney disease.

Authors:  Zachary Klinghoffer; Jean-Eric Tarride; Giacomo Novara; Vincenzo Ficarra; Anil Kapoor; Bobby Shayegan; Luis H Braga
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

5.  Laparoscopic versus open partial nephrectomy for clinical T1 renal masses: no impact of surgical approach on perioperative complications and long-term postoperative quality of life.

Authors:  Andreas Becker; Lea Pradel; Luis Kluth; Marianne Schmid; Christian Eichelberg; Sascha Ahyai; Quoc Trinh; Daniel Seiler; Roland Dahlem; Jens Hansen; Michael Rink; Mario Zacharias; Anja Mehnert; Corinna Bergelt; Margit Fisch; Felix K H Chun
Journal:  World J Urol       Date:  2014-05-31       Impact factor: 4.226

6.  Role of the Laparoscopic Approach for Complex Urologic Surgery in the Era of Robotics.

Authors:  Iulia Andras; Angelo Territo; Teodora Telecan; Paul Medan; Ion Perciuleac; Alexandru Berindean; Dan V Stanca; Maximilian Buzoianu; Ioan Coman; Nicolae Crisan
Journal:  J Clin Med       Date:  2021-04-21       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.